Rosemary Rochford
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Oncology, MicrobiologyGoogle:
"Rosemary Rochford"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Burnet AM, Brunetti T, Rochford R. (2023) Hemin treatment drives viral reactivation and plasma cell differentiation of EBV latently infected B cells. Plos Pathogens. 19: e1011561 |
| Smith NA, Coleman CB, Gewurz BE, et al. (2020) CD21 (Complement Receptor 2) is the receptor for Epstein-Barr virus entry into T cells. Journal of Virology |
| Oko LM, Kimball AK, Kaspar RE, et al. (2019) Multidimensional analysis of Gammaherpesvirus RNA expression reveals unexpected heterogeneity of gene expression. Plos Pathogens. 15: e1007849 |
| Reynaldi A, Dent AE, Schlub TE, et al. (2019) Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants. Malaria Journal. 18: 19 |
| Porcu P, Haverkos B, Brem E, et al. (2019) A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas. Journal of Clinical Oncology. 37: 7551-7551 |
| Porcu P, Haverkos B, Brem E, et al. (2019) A Phase 1B/2 Study Of Oral Nanatinostat (N) And Valganciclovir (Vg) In Subjects With Epstein-Barr Virus (Ebv)-Associated Lymphomas Hematological Oncology. 37: 335-337 |
| Smith NA, Baresel PC, Jackson CL, et al. (2018) Differences in the Epstein-Barr virus gp350 IgA antibody response are associated with increased risk for co-infection with a second strain of EBV. The Journal of Infectious Diseases |
| Coleman CB, Lang J, Sweet LA, et al. (2018) Epstein-Barr virus type-2 infects T-cells and induces B-cell lymphomagenesis in humanized mice. Journal of Virology |
| Ayers LW, Barbachano-Guerrero A, McAllister SC, et al. (2018) Mast cell activation and KSHV infection in Kaposi sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Bristol JA, Djavadian R, Albright ER, et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. Plos Pathogens. 14: e1007179 |